Search research articles
Contact Us
Filters
Showing results (101-110 of 121) with videos related to
Page
of 13
Sort By:
Blood Advances
|
December 24, 2019
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes
Caner Saygin, Ashwin Kishtagari, Ryan D Cassaday, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2021
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Aziz Nazha, Rami Komrokji, Manja Meggendorfer, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
November 9, 2025
A proposed path to explaining the unexplained anemia of aging
Nahed El Kassar, Amy E DeZern, Janis Abkowitz, et al.
Transplantation and Cellular Therapy
|
August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia
Sanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.
Nature Communications
|
April 26, 2017
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
Feng Pan, Thomas S Wingo, Zhigang Zhao, et al.
Leukemia
|
August 29, 2020
Revised 15-item MDS-specific frailty scale maintains prognostic potential
Bo A Wan, Aziz Nazha, Rebecca Starkman, et al.
Blood Cancer Journal
|
October 31, 2021
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Joshua F Zeidner, Tara L Lin, Carlos E Vigil, et al.
Blood
|
June 6, 2022
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis
Marie Robin, Liesbeth C de Wreede, Eric Padron, et al.
Leukemia
|
November 6, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms
Mrinal M Patnaik, Amer M Zeidan, Eric Padron, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 121) with videos related to
Sort By:
Page
of 13
Blood Advances
|
December 24, 2019
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes
Caner Saygin, Ashwin Kishtagari, Ryan D Cassaday, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2021
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Aziz Nazha, Rami Komrokji, Manja Meggendorfer, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
November 9, 2025
A proposed path to explaining the unexplained anemia of aging
Nahed El Kassar, Amy E DeZern, Janis Abkowitz, et al.
Transplantation and Cellular Therapy
|
August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia
Sanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.
Nature Communications
|
April 26, 2017
Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
Feng Pan, Thomas S Wingo, Zhigang Zhao, et al.
Leukemia
|
August 29, 2020
Revised 15-item MDS-specific frailty scale maintains prognostic potential
Bo A Wan, Aziz Nazha, Rebecca Starkman, et al.
Blood Cancer Journal
|
October 31, 2021
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Joshua F Zeidner, Tara L Lin, Carlos E Vigil, et al.
Blood
|
June 6, 2022
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis
Marie Robin, Liesbeth C de Wreede, Eric Padron, et al.
Leukemia
|
November 6, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms
Mrinal M Patnaik, Amer M Zeidan, Eric Padron, et al.
Page
of 13